Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
The Type I Interferon Response in Cancer Progression
FY 2018-19
Summary
Type I interferon (IFN-I) signalling plays a role in both immunosuppressive and inflammation during chronic infections such as chronic viral infections and cancer, however IFN-I signalling is poorly understood in the context of cancer. IFN-I signalling contributes to T cell exhaustion and the expression of immunosuppressive ligands such as PD-L1, while IFN-I signalling blockades increases the population of TCF1+ T cells that are essential to maintaining the immune response during a chronic viral infection. It is likely that IFN-I signalling plays a similar role in cancer. Improved understanding of IFN-I signalling on immunosuppression in the context of cancer is crucial to the development of therapeutics to counter this process in the tumour microenvironment, and allow the immune system to act against cancer cells. I propose using a cancer mouse model to study the effects of an IFN-I blockade of immune cell populations and the expression of immunoregulatory ligands and receptors in the tumour microenvironment through flow cytometry. Using this data, studies on IFN-I blockades as a combinatory immunotherapy with other immunotherapies such as PD-1/PD-L1 inhibitors can be conducted to investigate if there are any synergistic effects on tumour shrinkage. Combinatory therapy with IFN-I blockades could improve prognosis for cancers such as pancreatic cancers that are particularly resistant to current immunotherapies due to their high tumour burden leading to high immunosuppression.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406515
Name
Feng Emily
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Type I Interferon Response in Cancer Progression
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Immunosuppression; Immunotherapy; Interferon; T Cells; Viral Infection
Abstract
Type I interferon (IFN-I) signalling plays a role in both immunosuppressive and inflammation during chronic infections such as chronic viral infections and cancer, however IFN-I signalling is poorly understood in the context of cancer. IFN-I signalling contributes to T cell exhaustion and the expression of immunosuppressive ligands such as PD-L1, while IFN-I signalling blockades increases the population of TCF1+ T cells that are essential to maintaining the immune response during a chronic viral infection. It is likely that IFN-I signalling plays a similar role in cancer. Improved understanding of IFN-I signalling on immunosuppression in the context of cancer is crucial to the development of therapeutics to counter this process in the tumour microenvironment, and allow the immune system to act against cancer cells. I propose using a cancer mouse model to study the effects of an IFN-I blockade of immune cell populations and the expression of immunoregulatory ligands and receptors in the tumour microenvironment through flow cytometry. Using this data, studies on IFN-I blockades as a combinatory immunotherapy with other immunotherapies such as PD-1/PD-L1 inhibitors can be conducted to investigate if there are any synergistic effects on tumour shrinkage. Combinatory therapy with IFN-I blockades could improve prognosis for cancers such as pancreatic cancers that are particularly resistant to current immunotherapies due to their high tumour burden leading to high immunosuppression.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Feng, Emily
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~